LCM
NVO

Logan Capital Management’s Novo Nordisk NVO Stock Holding History

Logan Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,534
Closed -$681K – 621
2026
Q1 		$681K Buy
+18,534
New +$878K 0.03% 229

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Logan Capital Management's NVO Position: Q2 2026 in Review

Logan Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 18,512 shares worth $887K. The stake represents 0.03% of the portfolio and ranks #220 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in NVO as recently as Q4 2025.

Logan Capital Management first reported a position in NVO in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.22M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Logan Capital Management held 18,512 shares of Novo Nordisk worth $887K as of Q2 2026.
  • Novo Nordisk was a new Logan Capital Management position in Q2 2026.
  • Novo Nordisk made up 0.03% of Logan Capital Management's portfolio in Q2 2026, its #220 holding.
  • Logan Capital Management first reported a position in Novo Nordisk in Q1 2021 and has held it in 21 quarters since.
  • Logan Capital Management's Novo Nordisk position peaked at $4.22M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.